You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 68 No. 3, September 1962 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (49)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

IDU and Hydrocortisone in Experimental Herpes Simplex Keratitis

HERBERT E. KAUFMAN, M.D.; EMILY D. MALONEY

Arch Ophthalmol. 1962;68(3):396-398.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The indiscriminate clinical use of corticosteroids "when the eye is red" has contributed greatly to the severity and variety of herpes simplex keratitis.1,2 Similarly, the deleterious effects of corticosteroids on experimental herpes simplex keratitis have been well documented.3,4 Since, when used indiscriminately, corticosteroids are dangerous, and since the antiviral agents described to date are not effective in treating iritis or disease accompanied by folds in Descemet's membrane,5 it would be desirable if topical corticosteroids could be used with safety.

The preparation, 5-iodo-2'-deoxyuridine (IDU), is a specific antiviral agent that stops viral replication.6,7 The experiments described below document the effects of the combination of IDU with corticosteroids.

Methods and Materials

Albino rabbits were infected with strains of herpes simplex virus as previously described.6 Drops of IDU were administered as a 0.1% solution and hydrocortisone as a 0.5% solution. In some experiments, when the two were given . . . [Full Text PDF of this Article]


Author Affiliations

Gainesville, Fla.

Division of Ophthalmology, College of Medicine, University of Florida.


Footnotes

Submitted for publication May 22, 1962.

Supported in part by U.S. Public Health Service Grant B-3538 from the National Institute of Neurological Diseases and Blindness of the National Institutes of Health.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1962 American Medical Association. All Rights Reserved.